Livzon Pharmaceutical Group Inc. (SHE: 000513)
China
· Delayed Price · Currency is CNY 36.91
-0.19 (-0.51%)
Jan 3, 2025, 3:04 PM CST
Livzon Pharmaceutical Group Revenue
Livzon Pharmaceutical Group had revenue of 2.80B CNY in the quarter ending September 30, 2024, a decrease of -5.59%. This brings the company's revenue in the last twelve months to 11.86B, down -7.34% year-over-year. In the year 2023, Livzon Pharmaceutical Group had annual revenue of 12.43B, down -1.58%.
Revenue (ttm)
11.86B
Revenue Growth
-7.34%
P/S Ratio
2.88
Revenue / Employee
1.33M
Employees
8,933
Market Cap
29.88B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2023 | 12.43B | -199.54M | -1.58% |
| Dec 31, 2022 | 12.63B | 565.72M | 4.69% |
| Jan 1, 2022 | 12.06B | 1.54B | 14.67% |
| Jan 1, 2021 | 10.52B | 1.14B | 12.10% |
| Jan 1, 2020 | 9.38B | 524.04M | 5.91% |
| Dec 31, 2018 | Pro | Pro | Pro |
| Jan 1, 2018 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
| Dec 31, 2015 | Pro | Pro | Pro |
| Dec 31, 2014 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Shenzhen Mindray Bio-Medical Electronics | 37.11B |
| Jiangsu Hengrui Medicine | 26.00B |
| WuXi AppTec | 38.50B |
| Zhangzhou Pientzehuang Pharmaceutical., | 10.91B |
| Aier Eye Hospital Group | 20.62B |
| Shanghai United Imaging Healthcare | 10.93B |
| Yunnan Baiyao Group Co.,Ltd | 39.34B |
| Beijing Wantai Biological Pharmacy Enterprise | 2.49B |